PUBLISHER: Meticulous Research | PRODUCT CODE: 2176340
PUBLISHER: Meticulous Research | PRODUCT CODE: 2176340
The global Dental Materials Market was valued at USD 9,531.0 million in 2025. It is estimated to reach USD 9,919.8 million in 2026 and is projected to grow to USD 15,834.1 million by 2036, at a CAGR of 4.8% during the forecast period. This report offers a detailed look at the market, covering market dynamics, the impact of technology, the regulatory landscape, pricing, the value chain, competitive activity, and future growth opportunities.
The market covers the consumable materials used to restore, replace, bond, and record the shape of teeth and their supporting tissues, sold by manufacturers to dental clinics, hospitals, laboratories, milling centers, and academic institutes. It includes direct and indirect restoratives, CAD/CAM blocks and discs, printable crown and denture resins, bone grafts, membranes, impression materials, bonding agents, and cements. Finished restorations sold by laboratories, implants, orthodontic products, anesthetics, and equipment such as mills, scanners, and 3D printers are excluded.
Oral diseases affect about 3.7 billion people worldwide, according to the WHO (March 2025), and this untreated burden sets the long-term demand for dental materials. The move from porcelain-fused-to-metal crowns to monolithic zirconia, the end of dental amalgam in the EU, and the spread of intraoral scanning and 3D printing are changing which materials clinics and laboratories buy. At the same time, out-of-pocket treatment costs, payer price controls, and the uneven supply of dentists shape the pace of growth across countries.
The report examines market drivers, restraints, opportunities, challenges, and trends, as well as the impact of CAD/CAM, advanced ceramics, bioactive biomaterials, 3D printing, and AI on the market. It also covers the regulatory landscape by region, distributor pricing by material category, the value chain, and Porter's five forces. In addition, it provides market forecasts in value, segment-level insights, and regional analysis across 5 regions, 17 countries, and 4 rest-of-region groups.
Market Dynamics
The high prevalence of caries, periodontal disease, and tooth loss is the main force behind market growth. Rising demand for cosmetic dentistry and dental tourism adds to it, with dentistry the leading specialty among the more than 691,000 international health tourists who visited Dubai in 2023, according to the Dubai Health Authority. Aging populations that keep more natural teeth for longer, together with rising edentulism among older adults, further support demand for crowns, dentures, and implant-related biomaterials.
The high cost of dental treatment limits patient access in price-sensitive markets, where patients largely pay out of pocket and often choose lower-cost local brands. Biocompatibility testing and regulatory work also raise the cost of bringing new materials to market, as seen in the higher certification costs under the EU Medical Device Regulation. In addition, the shortage of dental professionals in developing markets and reimbursement limits that cover only basic materials remain major challenges for the shift to ceramics, universal adhesives, and biomaterials.
The adoption of CAD/CAM and digital dentistry workflows, the growing focus on bioactive and biocompatible biomaterials, and the regulatory phase-down of dental amalgam offer significant opportunities. Parties to the Minamata Convention agreed in November 2025 to end the use of dental amalgam by 2034. Meanwhile, 3D printing of definitive restorations, rising demand for zirconia and other tooth-colored materials, and the integration of AI in digital workflows are shaping the next product generations, with 72% of U.S. dental laboratories using 3D printers in 2025, according to the NADL Dental Technology Survey.
Segment Analysis
The report analyzes the market by type, end user, and geography, with further sub-segmentation of each material type, helping stakeholders identify the most promising growth opportunities.
Based on type, the market is segmented into indirect restorative materials, direct restorative materials, dental biomaterials, impression materials, bonding agents, and dental cements & liners. In 2026, indirect restorative materials are expected to hold the largest share, supported by the high value of crowns, bridges, and dentures. Dental biomaterials are expected to grow the fastest as bone grafts and membranes follow the rise in implant procedures.
Based on indirect restorative materials, the market is segmented into metal-ceramics, ceramics, and other indirect restorative materials, with ceramics further segmented into zirconia, lithium disilicate glass ceramics, and other ceramics. In 2026, ceramics are expected to hold the largest share and to grow the fastest, led by zirconia, while metal-ceramics decline as laboratories replace porcelain-fused-to-metal crowns with monolithic zirconia.
Based on direct restorative materials, the market is segmented into resin-based composites, glass ionomer, amalgam, and other direct restorative materials. In 2026, resin-based composites are expected to hold the largest share and to grow the fastest, as they take most of the demand released by amalgam. Amalgam declines sharply after the EU ban and the agreed global phase-out.
Based on dental biomaterials, the market is segmented into dental bone grafts, including allografts, xenografts, and alloplastic/synthetic bone graft substitutes, membranes, including resorbable and non-resorbable membranes, and other dental biomaterials. In 2026, dental bone grafts are expected to hold the largest share, led by xenografts, while membranes are expected to grow the fastest and synthetic substitutes are the fastest-growing graft type.
Based on impression materials, the market is segmented into vinyl polysiloxane, polyether, alginate, and other impression materials. In 2026, vinyl polysiloxane is expected to hold the largest share and to grow the fastest, as it remains the main material for final impressions of crowns and implants. However, intraoral scanning slows growth across this segment.
Based on bonding agents, the market is segmented into total-etch, self-etch, and universal bonding agents. In 2026, universal bonding agents are expected to hold the largest share and to grow the fastest, because one bottle can serve direct composites, indirect restorations, and bonding to zirconia and metal.
Based on dental cements & liners, the market is segmented into resin cements, glass ionomer & resin-modified glass ionomer cements, and other cements & liners. In 2026, resin cements are expected to hold the largest share and to grow the fastest, supported by the adhesive cementation of zirconia and glass ceramic restorations.
Based on end user, the market is segmented into dental clinics & hospitals, dental laboratories, dental products manufacturers & milling centers, and academic & research institutes. In 2026, dental clinics & hospitals are expected to hold the largest share, as they buy almost all direct restoratives, bonding agents, and biomaterials. Dental products manufacturers & milling centers are expected to grow the fastest with the centralization of zirconia milling and 3D printing.
Regional Analysis
The report covers North America, Europe, Asia-Pacific, Latin America, and the Middle East & Africa, spanning 17 countries and 4 rest-of-region groups. Market values are attributed to the country where materials are bought and used, and the analysis considers dentist density, payment systems, amalgam rules, digital adoption, and local manufacturing in each region.
In 2026, North America is expected to account for the largest share of the global market, led by the U.S., which has high dental spending and a large installed base of dentists and laboratories. Europe is the second-largest region, with Germany as its largest country market, but it grows more slowly because amalgam has already been removed and public payers cap spending on advanced materials.
The Middle East & Africa is expected to grow the fastest during the forecast period, supported by private health care expansion in Saudi Arabia and dental tourism in the UAE. Among countries, the U.S. is the largest market, China is second and leads Asia-Pacific on the back of implant growth after national bulk-buying of implants, Brazil leads Latin America, and India is the fastest-growing individual country.
Competitive Landscape
The report provides a detailed review of the competitive landscape, covering key growth strategies, market differentiators, major deals and strategic alliances, the competitive dashboard, vendor market positioning by material type, and market share analysis. It also profiles 17 leading companies, covering their financial performance, product portfolios, strategy and market position, strategic developments, and SWOT analyses.
Based on 2025 market share, Ivoclar ranked first, followed by Solventum, GC, Dentsply Sirona, Kulzer, and Kuraray Noritake. Product launches are the main strategy, focused on multilayer zirconia, printable resins, universal adhesives, and new collagen membranes, many of them presented at IDS 2025 in Cologne. Consolidation also continued, led by the acquisition of Ultradent by Mitsui Chemicals, the parent of Kulzer, which was completed in August 2026.
The vendor market positioning compares companies across indirect restoratives, direct restoratives, biomaterials, impression materials, bonding agents, and cements & liners. Companies compete on material science, clinical evidence, shade and handling, education networks, and integration with mills, printers, and scanners, while lower-priced zirconia from Chinese makers adds price pressure in ceramics.
Key companies profiled in the report include Dentsply Sirona Inc. (U.S.), Institut Straumann AG (Switzerland), Envista Holdings Corporation (U.S.), Solventum Corporation (U.S.), Kuraray Noritake Dental Inc. (Japan), Ivoclar Vivadent AG (Liechtenstein), GC Corporation (Japan), Kulzer GmbH (Germany), Ultradent Products, Inc. (U.S.), VOCO GmbH (Germany), Tokuyama Dental Corporation (Japan), Shofu Inc. (Japan), DMG Chemisch-Pharmazeutische Fabrik GmbH (Germany), Septodont Holding (France), Coltene Holding AG (Switzerland), VITA Zahnfabrik H. Rauter GmbH & Co. KG (Germany), and Geistlich Pharma AG (Switzerland).
How This Report Helps
Key Questions Answered